Shannon James Samuel (CIK 1485417) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-30). Recent activity: Buy XLO (5,000 shares), Buy MNKD (12,000 shares), Buy XLO (45,000 shares), Buy XLO (25,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | Xilio Therapeutics, Inc. (XLO) | Director | Buy | 5,000 | $43,950 |
| 2026-03-03 | MANNKIND CORP (MNKD) | Director | Buy | 12,000 | $39,240 |
| 2025-06-18 | Xilio Therapeutics, Inc. (XLO) | Director | Buy | 45,000 | $0 |
| 2025-06-18 | Xilio Therapeutics, Inc. (XLO) | Director | Buy | 25,000 | $0 |
Source: SEC Form 4 filings · as of 2026-03-30